newsfilter
← Latest News
Business Wire·

Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced today the appointment of